SHA:600829 Market Cap

SHA:600829 has a market cap or net worth of 6.08 billion as of March 10, 2026. Its market cap has increased by 36.23% in one year.

Market Cap

6.08B

Enterprise Value

6.20B

Revenue

10.22B

Ranking

n/a

PE Ratio

51.05

Stock Price

10.49

Market Cap Chart

Since May 17, 2006, SHA:600829's market cap has increased from 3.63B to 6.08B, an increase of 67.75%. That is a compound annual growth rate of 2.64%.

Market Cap History

Date	Market Cap	% Change
Mar 10, 2026	6.08B	-2.96%
Dec 31, 2025	6.27B	44.13%
Dec 31, 2024	4.35B	-4.09%
Dec 29, 2023	4.53B	22.57%
Dec 30, 2022	3.70B	-5.06%
Dec 31, 2021	3.90B	-9.43%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Beijing Beilu Pharmaceutical	6.11B
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	6.03B
ChengDu ShengNuo Biotec	5.98B
Guizhou Xinbang Pharmaceutical	6.32B
Shanxi Zhendong Pharmaceutical Co.,Ltd	5.91B
Jinghua Pharmaceutical Group	6.36B
Chongqing Pharscin Pharmaceutical	5.90B
Beijing SL Pharmaceutical	6.43B

Market Cap Rankings